Factors Associated with Exchange Transfusion among Severe Neonatal Jaundice in Malaysia

Document Type : Original Article

Authors

1 Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia

2 Kelantan State Health Department, Ministry of Health, Malaysia

Abstract

Background: Neonatal jaundice may lead to a severe level if it is not well monitored. The long-term consequences of severe neonatal jaundice may result in devastating neurologic sequelae, including bilirubin encephalopathy and kernicterus. Exchange transfusion has remained the most effective modality for lowering serum bilirubin concentration. The present study aimed to determine the proportion and factors associated with exchange transfusion procedure among neonates with severe jaundice in Kelantan from 2015 to 2017.
Methods: This cross-sectional study was carried out among neonates with severe jaundice in Kelantan between 2015 and 2017 using jaundice surveillance data from Kelantan Health State Department.
Result: Out of the study subjects, 45 (19.7%) neonates had severe jaundice requiring an exchange transfusion procedure. From 2015 to 2017, the prevalence of severe neonatal jaundice requiring exchange transfusion raised from 17.0%-23.7%. The significant factors associated with exchange transfusion were neonatal infection, low birth weight, ABO blood group incompatibility, and maternal blood type O.
Conclusion: As evidenced by the obtained results, exchange transfusion among severe neonatal jaundice in Kelantan followed an increasing trend within the study period. Associated factors leading to exchange transfusion among severe neonatal jaundice were neonatal infection, low birth weight, ABO incompatibility, and maternal blood type O. The recognition of these factors would be of great help in developing effective strategies aimed at the prevention of exchange transfusion procedure and its subsequent complications.
 
 

Keywords

References

  1. Stevenson D, Maisels J, Watchko J. Care of the Jaundiced neonate. New York: McGraw Hill Education; 2012.
  2. Korejo HB, Bhurgri GR, Bhand S, Qureshi MA, Dahri GM, Chohan RK. Risk factors for kernicterus in neonatal jaundice. Gomal J Med Sci. 2010; 8(1):12-8.
  3. Ballot DE, Rugamba G. Exchange transfusion for neonatal hyperbilirubinemia in Johannesburg, South Africa, from 2006 to 2011. Int Sch Res Notices. 2016; 2016:1268149.
  4. Begum S, Baki A, Kundu G, Islam I, Talukdar MK, Fatema K. Exchange transfusion: indication and adverse effect. Bangladesh J Child Health. 2012; 36(1):16-9.
  5. Steiner LA, Bizzarro MJ, Ehrankranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007; 120(1):
    27-32.
  6. Sakha SH, Gharehbaghi MM. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. Turk J Paediatr. 2010; 52(4):367-71.
  7. Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol. 2011; 35(3):175-84.
  8. Ekure EN, Akintan PE, Fajolu IB, Ezenwa BN, Ezeaka VC. Mothers’ perception of neonatal jaundice in Lagos, Nigeria: An urgent need for greater awareness. South Afr J Child Health. 2016; 10(4):227-30.
  9. Henny-Harry C, Trotman H. Epidemiology of neonatal jaundice at the University Hospital of the West Indies. West Indian Med J. 2012; 61(1):37-42.

10. Pius S, Bello M, Mava Y, Djossi S, Ambe JP. Prevalence of exchange blood transfusion in severe hyperbilirubinaemia and outcome at the University of Maiduguri Teaching Hospital Maiduguri, Northeastern Nigeria. Niger J Paediatr. 2017; 44(2):50-5.

11. Malla T, Singh S, Poudyal P, Sathian B, Malla KK. A prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia - in a tertiary care hospital, Nepal. Kathmandu Univ Med J. 2015; 50(2):102-8.

12. Heydarian F, Majdi M. Severe neonatal hyperbilirubinemia: causes and contributing factors leading to exchang transfusion at Ghaem hospital in Mashad. Acta Med Iran. 2010; 48(6):399-402.

13. Behjati, Sagheb S, Aryasepehr S, Yaghmai. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009; 76(1):83-5.

14. Bujandric N, Grujic J. Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years' experience from Vojvodina, Serbia. Indian J Hematol Blood Transfus. 2016; 32(2):208-14.

15. Sgro M, Kandasamy S, Shah V, Ofner M, Campbell D. Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines. J Pediatr. 2016; 171:43-7.

16. Arnolda G, Nwe HM, Trevisanuto D, Thin AA, Thein AA, Defechereux T, et al. Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals. Matern Health Neonatol Perinatol. 2015; 1:22.

17. Bhutani VK, Meng NF, Knauer Y, Danielsen BH, Wong RJ, Stevenson DK, et al. Extreme hyperbilirubinemia and rescue exchange transfusion in California from 2007 to 2012. J Perinatol. 2016; 36(10):853-7.

18. Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009; 5(1):51-5.

19. Menon S, Amanullah N. Maternal and neonatal determinants of neonatal jaundice–a case control study. J Med Sci Clin Res. 2017; 5(3):19659-65.

20. Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology. 2011; 100(4):354-62.

21. Olusanya BO, Akande AA, Emokpae A, Olowe SA. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Trop Med Int Health. 2009; 14(3):301-10.

22. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology. 2011; 100(1):57-63.

23. Audu LI, Mairami AB, Otuneye AT, Mohammed-Nafi’u R, Mshelia LJ, Nwatah VE, et al. Identifying modifiable socio-demographic risk factors for severe hyperbilirubinaemia in late preterm and term babies in Abuja, Nigeria. J Adv Med Med Res. 2016; 16(8):1-11.

24. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, et al. Incidence, etiology, and outcomes of hazardous hyperbi-lirubinemia in newborns. Pediatrics. 2014; 134(3):
504-9.

25. Badiee. Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan, Iran. Singapore Med J. 2007; 48(5):421-3.

26. Esfandiarpour B, Ebrahimi H, Karkan MF, Farahmand N, Karambin MM. Neonatal exchange transfusion for hyperbilirubinemia in Guilan (the north province of Iran): a 3-year experience. Turk J Pediatr. 2012; 54(6):626-31.

27. Erdeve O, Okulu E, Olukman O, Ulubas D, Buyukkale G, Narter F, et al. The Turkish neonatal jaundice online registry: a national root cause analysis. PLoS One. 2018; 13(2):e0193108.

 

 


 

Iranian Journal of Neonatology
Volume 12, Issue 3
July 2021
Pages 7-12

Files

Share

How to cite

Statistics